Front Row Advisors LLC Agenus Inc Transaction History

Front Row Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 22, 2023	BUY	$1.45 - $2.95 $145 - $295	100 New	100 $0
Q2 2022 Aug 15, 2022	SELL	$1.3 - $2.64 $130 - $264	-100 Closed	0 $0
Q2 2021 Aug 23, 2021	BUY	$2.56 - $5.49 $256 - $549	100 New	100 $1,000
Q1 2021 Apr 28, 2021	SELL	$2.69 - $5.25 $269 - $525	-100 Closed	0 $0
Q1 2019 May 17, 2019	BUY	$2.51 - $3.73 $250 - $373	100 New	100 $0

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Front Row Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Front Row Advisors LLC with notifications on news.